Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
D000225:Adenine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000737:chemistry; D000818:Animals; D000942:Antigens, Bacterial; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D001427:Bacterial Toxins; D001665:Binding Sites; D016466:CHO Cells; D002460:Cell Line; D006224:Cricetinae; D000242:Cyclic AMP / Q000378:metabolism; D005098:Exotoxins / Q000037:antagonists & inhibitors; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D007700:Kinetics; D008958:Models, Molecular; D063065:Organophosphonates; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors; D018411:Spodoptera; D014162:Transfection
D000067956:Adenylyl Cyclase Inhibitors; D000942:Antigens, Bacterial; D000998:Antiviral Agents; D001427:Bacterial Toxins; D005098:Exotoxins; D063065:Organophosphonates; D011994:Recombinant Proteins; C030325:anthrax toxin; C053001:adefovir; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000225:Adenine; C106812:adefovir dipivoxil